Leslie M. Magnus
Corporate Officer/Principal at SYNERGY PHARMACEUTICALS INC
Leslie M. Magnus active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 31/12/2014 | - |
| Chief Tech/Sci/R&D Officer | 31/12/2014 | - |
Career history of Leslie M. Magnus
Former positions of Leslie M. Magnus
| Companies | Position | Start | End |
|---|---|---|---|
UCB Pharma, Inc.
 UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Chief Tech/Sci/R&D Officer | - | - |
Training of Leslie M. Magnus
| Brown University | Undergraduate Degree |
| Albany State University (Georgia) | Graduate Degree |
Statistics
International
| United States | 5 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Commercial Services |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Leslie M. Magnus
- Experience
